Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Similac "1st Choice" claim

This article was originally published in The Tan Sheet

Executive Summary

Chicago appeals court denies Mead Johnson's request for full court review of a three-judge panel's Jan. 5 opinion overturning a preliminary injunction restricting Abbott Labs' use of the "1st Choice of Doctors" claim for Similac infant formula. The court's April 12 ruling leaves intact the panel's conclusion that Mead's consumer survey evidence was inadequate to demonstrate Abbott's claim was false (1"The Tan Sheet" Jan. 17, p. 4). The appeals court also denies Abbott's request to direct the lower court to increase a $1 mil. bond posted by Mead. Abbott says it plans to start using the claim again on product packaging and promotional materials "in the near future"
Advertisement

Related Content

Similac "1st Choice Of Doctors" Claim Injunction Reversed
Similac "1st Choice Of Doctors" Claim Injunction Reversed

Topics

Advertisement
UsernamePublicRestriction

Register

PS091132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel